Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Th9 Cells Expression and Eosinophils Activity in the Course of Allergic Airway Diseases

NCT02214303 is registered in ClinicalTrials.gov with Lithuanian University of Health Sciences as lead sponsor.

NCT NCT02214303
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02214303 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Th9 Cells Expression and Eosinophils Activity in the Course of Allergic Airway Diseases
Lead sponsor
Lithuanian University of Health Sciences
Phase
Observational
Overall status
Unknown status
Start date
April 30, 2013
Completion date
December 31, 2015
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

allergic asthma, allergic rhinitis